Skip to content

13F-HR filed by HARVARD MANAGEMENT CO INC

HARVARD MANAGEMENT CO INC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-09, with 17 holding rows worth $405,098,000.

Accession
0000950123-19-007448
Filed
2019-08-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 17 entries on the cover page, a total value of $405,098,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $405,098,000 with VALUE read as thousands by filing date, 13F file number 028-03879. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Alphabet Inc. Reg. Shares A02079K305COM112,346$121,648,000thousands by filing date
Apple Inc037833100COM506,683$100,283,000thousands by filing date
Booking Holdings Inc.09857L108COM25,674$48,131,000thousands by filing date
META PLATFORMS INC CL A30303M102COM170,081$32,826,000thousands by filing date
ISHARES TR CORE S&P 500 ETF464287200SHS72,147$21,265,000thousands by filing date
Vanguard FTSE Developed Markets ETF921943858SHS329,167$13,730,000thousands by filing date
SPDR GOLD TR78463V107GOLD SHS101,467$13,515,000thousands by filing date
PALO ALTO NETWORKS INC697435105COM54,006$11,004,000thousands by filing date
INVESCO QQQ TR46090E103COM50,474$9,426,000thousands by filing date
VWO922042858SHS187,728$7,984,000thousands by filing date
VANGUARD WORLD FD921910709EXTENDED DUR54,247$6,890,000thousands by filing date
IJH464287507COM26,759$5,198,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock332,610$4,906,000thousands by filing date
iShares Core S&P Small-Cap ETF464287804SHS58,484$4,578,000thousands by filing date
NEON THERAPEUTICS INC64050Y100COM505,871$2,398,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock640,595$987,000thousands by filing date
Vanguard Dividend Appreciation ETF921908844SHS2,858$329,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-19-007448this filing2019-08-09acceptance time not in the bulk data set